PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Korean Journal of Ophthalmology10.3341/kjo.2014.28.2.1772014282177Ranibizumab Injection for Corneal Neovascularization Refractory to Bevacizumab TreatmentYe Jin Ahn, Hyung Bin Hwang, Sung Kun Chunghttps://synapse.koreamed.org/DOIx.php?id=10.3341/kjo.2014.28.2.177, https://synapse.koreamed.org/pdf/10.3341/kjo.2014.28.2.177, http://synapse.koreamed.org/DOIx.php?id=10.3341/kjo.2014.28.2.177
Case Reports in Ophthalmology10.1159/0005101142020113652-657Resolution of Refractory Corneal Neovascularization with Subconjunctival BevacizumabAnna Krystyna Britton, Basil Bamford Crayfordhttps://www.karger.com/Article/Pdf/510114, https://www.karger.com/Article/Pdf/510114
Acta Ophthalmologica10.1111/j.1755-3768.2008.01399.x2009876653-658Therapeutic effect of subconjunctival injection of bevacizumab in the treatment of corneal neovascularizationIn-Cheon You, In-Seong Kang, Seung-Hyun Lee, Kyung-Chul Yoonhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1755-3768.2008.01399.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1755-3768.2008.01399.x/fullpdf
European Journal of Ophthalmology10.5301/ejo.50006912015263262-267Ranibizumab versus Bevacizumab for the Treatment of Idiopathic Choroidal Neovascularization: 2-Year ResultsPengyi Zhou, Lin Yang, Xuemin Jinhttp://journals.sagepub.com/doi/pdf/10.5301/ejo.5000691, http://journals.sagepub.com/doi/full-xml/10.5301/ejo.5000691, http://journals.sagepub.com/doi/pdf/10.5301/ejo.5000691
Journal of the Korean Ophthalmological Society10.3341/jkos.2017.58.8.9812017588981Two Cases of Corneal Neovascularization Improved by Electrocauterization and Subconjunctival Bevacizumab InjectionJun Soo Eun, Kyong Jin Chohttps://synapse.koreamed.org/pdf/10.3341/jkos.2017.58.8.981, https://synapse.koreamed.org/DOIx.php?id=10.3341/jkos.2017.58.8.981, https://synapse.koreamed.org/DOIx.php?id=10.3341/jkos.2017.58.8.981
Journal of Ophthalmology10.1155/2016/6084270201620161-4Intrastromal Injection of Bevacizumab in the Management of Corneal Neovascularization: About 25 EyesBelghmaidi Sarah, Hajji Ibtissam, Baali Mohammed, Soummane Hasna, Moutaouakil Abdeljalilhttp://downloads.hindawi.com/journals/joph/2016/6084270.pdf, http://downloads.hindawi.com/journals/joph/2016/6084270.xml, http://downloads.hindawi.com/journals/joph/2016/6084270.pdf
International Ophthalmology10.1007/s10792-013-9732-82013335507-513The effect of different doses of subconjunctival bevacizumab injection on corneal neovascularizationBanu Torun Acar, Elvin Halili, Suphi Acarhttp://link.springer.com/content/pdf/10.1007/s10792-013-9732-8.pdf, http://link.springer.com/article/10.1007/s10792-013-9732-8/fulltext.html, http://link.springer.com/content/pdf/10.1007/s10792-013-9732-8
Acta Ophthalmologica10.1111/j.1755-3768.2009.2224.x2009870-0Subconjunctival injection of bevacizumab (Avastin®) for corneal neovascularizationMF DE LA PAZ, F DE SOUSA, C PONCE, J ALVAREZ, RI BARRAQUERhttp://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1755-3768.2009.2224.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1755-3768.2009.2224.x/fullpdf
Saudi Journal of Ophthalmology10.1016/j.sjopt.2017.02.008201731299-105Topical versus subconjunctival anti-vascular endothelial growth factor therapy (Bevacizumab, Ranibizumab and Aflibercept) for treatment of corneal neovascularizationTariq Al-Debasi, Abdulkareem Al-Bekairy, Abdulmalik Al-Katheri, Shmeylan Al Harbi, Mahmoud Mansourhttps://api.elsevier.com/content/article/PII:S1319453417300310?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1319453417300310?httpAccept=text/plain
Korean Journal of Ophthalmology10.3341/kjo.2013.27.4.2352013274235The Effect of Bevacizumab versus Ranibizumab in the Treatment of Corneal Neovascularization: A Preliminary StudyJin-Hyoung Kim, Hae-Won Seo, Hyun-Cheol Han, Jong-Hyun Lee, Suk-Kyue Choi, Doh Leehttps://synapse.koreamed.org/DOIx.php?id=10.3341/kjo.2013.27.4.235, https://synapse.koreamed.org/pdf/10.3341/kjo.2013.27.4.235, http://synapse.koreamed.org/DOIx.php?id=10.3341/kjo.2013.27.4.235